Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-19-006186

President sold 85,220 shares at an average $40.40 ($3,443,037)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2019-03-01 Sale −8,693 $40.01 $347,796 1,024,534 D
Novak Rodger President 2019-03-04 Sale −64,115 $40.24 $2,580,186 960,419 D
Novak Rodger President 2019-03-04 Sale −8,912 $41.29 $367,949 951,507 D
Novak Rodger President 2019-03-04 Sale −3,500 $42.03 $147,105 948,007 D
Open-market sales · 85,220 sh · avg $40.40 · $3,443,037
Loading xslF345X03/doc4.xml…